Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Scopolamine Hydrobromide in pCLE for Gastroendoscopy
NCT02811341Phase 1Completed
- Sponsor
- Shandong University
- Start
- Aug 2014
- Primary completion
- Feb 2015
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of scopolamine in gastrointestinal spasm (2 arms), sponsored by Shandong University. Primary endpoint: endomicroscopic image quality at 7 months. Started Aug 2014; status: completed.
02
Drugs
scopolamine
03
Conditions
gastrointestinal spasm
Beyond the preview
Go deeper on NCT02811341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02811341.